Precigen (PGEN) Return on Sales (2012 - 2026)

Precigen (PGEN) has 15 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, up 40.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.07% (up 29.0% YoY), and the FY2025 annual result was 0.26%, changed N/A from the prior year.
• Return on Sales grew to 0.0% in Q1 2026 per PGEN's latest filing, from 0.05% in the prior quarter.
• Over five years, Return on Sales peaked at 0.54% in Q3 2022 and troughed at 7.84% in Q2 2025.
• A 5-year average of 0.8% and a median of 0.14% in 2024 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 132 bps in 2025 and fell as far as 696 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.26% in 2022, then jumped by 65 bps to 0.09% in 2023, then plunged by 50 bps to 0.14% in 2024, then surged by 62 bps to 0.05% in 2025, then surged by 93 bps to 0.0% in 2026.
• Business Quant data shows PGEN's Return on Sales at 0.0% in Q1 2026, 0.05% in Q4 2025, and 0.87% in Q3 2025.